trilithium citrate
Approved
Dec 23, 1980
Lithium citrate (Li3C6H5O7) is a lithium salt of citric acid that is used as a mood stabilizer in psychiatric treatment of manic states and bipolar disorder. There is extensive pharmacology of lithium, the active component of this salt. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 8 marketing orgs
Timeline
1980s
- Dec 23, 1980
Hikma — Earliest FDA Approval
- Dec 23, 1980
West-Ward Pharmaceutical — NDA Secondary Org
- Dec 23, 1980
Hikma — NDA Secondary Org
- Dec 23, 1980
Hikma — Marketing Organization
- Dec 23, 1980
Hikma — NDA Organization
- May 21, 1986
Pharmaceutical Associates — Marketing Organization
- May 21, 1986
Wockhardt — Marketing Organization
2020s
- Aug 14, 2023
Rubicon Research — Marketing Organization
- Mar 18, 2024
Sciegen Pharmaceticals — Marketing Organization
- Mar 18, 2024
Saptalis Pharmaceuticals — Marketing Organization
Indications
Approved for
Mechanism of action
- Inositol-1(or 4)-monophosphatase 1INHIBITOR
IMPA1 inhibitor
- Glycogen synthase kinase-3INHIBITOR
Glycogen synthase kinase-3 inhibitor
Approval history
- approvedDec 23, 1980
Chemistry & pharmacology
SMILES
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]- Mol. weight
- 209.92 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Prescription Only
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1201170 ↗
- WikipediaLithium citrate ↗
- ChEMBLCHEMBL2103738 ↗
Also known as
- li-liquid
- litarex
- litarex
- litarex
- lithium citrate
- lithium citrate
- lithium citrate
- lithium citrate
- lithium citrate
- lithium citrate
- lithium citrate hydrate
- lithium citrate hydrate
- lithium citrate hydrate
- monolithium citrate
- trilithium citrate
Organizations
Marketing (11)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Hikma | For profit | NDA2 | Dec 23, 1980 |
| Hikma | For profit | MKTG | Dec 23, 1980 |
| Hikma | For profit | NDA | Dec 23, 1980 |
| Pharmaceutical Associates | For profit | MKTG | May 21, 1986 |
| Rubicon Research | For profit | MKTG | Aug 14, 2023 |
| Rubicon Research | For profit | SYN | Aug 14, 2023 |
| Saptalis Pharmaceuticals | For profit | MKTG | Mar 18, 2024 |
| Sciegen Pharmaceticals | For profit | MKTG | Mar 18, 2024 |
| Solvay | For profit | NDA2 | — |
| West-Ward Pharmaceutical | For profit | NDA2 | Dec 23, 1980 |
| Wockhardt | For profit | MKTG | May 21, 1986 |